These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 6679948

  • 1. Identification of 5 beta-cholestane-3 alpha, 7 alpha, 12 alpha, 25, 26-pentol in cerebrotendinous xanthomatosis.
    Dayal B, Tint GS, Greeley DN, Williams TH, Salen G.
    Steroids; 1983 Oct; 42(4):441-8. PubMed ID: 6679948
    [Abstract] [Full Text] [Related]

  • 2. Bile alcohol profiles in bile, urine, and feces of a patient with cerebrotendinous xanthomatosis.
    Shimazu K, Kuwabara M, Yoshii M, Kihira K, Takeuchi H, Nakano I, Ozawa S, Onuki M, Hatta Y, Hoshita T.
    J Biochem; 1986 Feb; 99(2):477-83. PubMed ID: 3700361
    [Abstract] [Full Text] [Related]

  • 3. Configurational assignment of 5 beta-cholestane-3 alpha, 7 alpha, 12 alpha, 23, 25-pentol excreted by patients with cerebrotendinous xanthomatosis (a circular dichroism study).
    Dayal B, Tint GS, Shefer S, Salen G.
    Steroids; 1979 Mar; 33(3):327-38. PubMed ID: 442127
    [Abstract] [Full Text] [Related]

  • 4. Identification of pentahydroxy bile alcohols in cerebrotendinous xanthomatosis: characterization of 5beta-cholestane-3alpha, 7alpha, 12alpha, 24xi, 25-pentol and 5beta-cholestane-3alpha, 7alpha, 12alpha, 23xi, 25-pentol.
    Shefer S, Dayal B, Tint GS, Salen G, Mosbach EH.
    J Lipid Res; 1975 Jul; 16(4):280-6. PubMed ID: 1141769
    [Abstract] [Full Text] [Related]

  • 5. Synthesis and structure of 26 (or 27)-nor-5 beta-cholestane-3 alpha,7 alpha,12 alpha,24S,25 xi-pentol isolated from the urine and feces of a patient with sitosterolemia and xanthomatosis.
    Dayal B, Tint GS, Toome V, Batta AK, Shefer S, Salen G.
    J Lipid Res; 1985 Mar; 26(3):298-305. PubMed ID: 2985722
    [Abstract] [Full Text] [Related]

  • 6. Determination of the glucurono-conjugated position in bile alcohol glucuronides present in a patient with cerebrotendinous xanthomatosis.
    Kuramoto T, Suemura Y, Kihira K, Hiraoka T, Hoshita T.
    Steroids; 1995 Oct; 60(10):709-12. PubMed ID: 8539780
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Identifications of 5 beta-cholestane-3 alpha, 7 alpha, 12 alpha, 23 beta-tetrol, 5 beta-cholestane-3 alpha, 7 alpha, 12 alpha, 24 alpha-tetrol, and 5 beta-cholestane-3 alpha, 7 alpha, 12 alpha, 24 beta-tetrol in cerebrotendinous xanthomatosis.
    Yasuhara M, Kuramoto T, Hoshita T, Itoga E, Kito S.
    Steroids; 1978 Mar; 31(3):333-45. PubMed ID: 663972
    [Abstract] [Full Text] [Related]

  • 9. Identification of (23S)-5 alpha-cholestane-3 alpha,7 alpha,12 alpha,23,25-pentol in urine of patients with cerebrotendinous xanthomatosis.
    Kihira K, Fukuda K, Kuramoto T, Kuriyama M, Fujiyama J, Osame M, Hoshita T.
    Steroids; 1991 Sep; 56(9):464-8. PubMed ID: 1805458
    [Abstract] [Full Text] [Related]

  • 10. Absolute configuration at carbon 23 of 5 beta-cholestane-3 alpha,7 alpha,12 alpha,23,25-pentol excreted by patients with cerebrotendinous xanthomatosis.
    Kihira K, Kubota A, Hoshita T.
    J Lipid Res; 1984 Aug; 25(8):871-5. PubMed ID: 6491531
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cholic acid biosynthesis: the enzymatic defect in cerebrotendinous xanthomatosis.
    Salen G, Shefer S, Cheng FW, Dayal B, Batta AK, Tint GS.
    J Clin Invest; 1979 Jan; 63(1):38-44. PubMed ID: 762246
    [Abstract] [Full Text] [Related]

  • 13. A biochemical abnormality in cerebrotendinous xanthomatosis. Impairment of bile acid biosynthesis associated with incomplete degradation of the cholesterol side chain.
    Setoguchi T, Salen G, Tint GS, Mosbach EH.
    J Clin Invest; 1974 May; 53(5):1393-401. PubMed ID: 4825231
    [Abstract] [Full Text] [Related]

  • 14. Occurrence of bile alcohol glucuronides in bile of patients with cerebrotendinous xanthomatosis.
    Hoshita T, Yasuhara M, Une M, Kibe A, Itoga E, Kito S, Kuramoto T.
    J Lipid Res; 1980 Nov; 21(8):1015-21. PubMed ID: 7462799
    [Abstract] [Full Text] [Related]

  • 15. Configuration at C-25 in 5 beta-cholestane-3 alpha,7 alpha,12 alpha,25,26-pentol excreted by patients with cerebrotendinous xanthomatosis: circular dichroism and 13C-NMR studies.
    Dayal B, Salen G, Toome V, Tint GS.
    J Lipid Res; 1986 Dec; 27(12):1328-32. PubMed ID: 3559396
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Synthesis of 5 beta-cholestane-3 alpha,6 beta,7 alpha,25,26-pentol and identification of a novel bile alcohol, alpha-trichechol, present in the West Indian manatee bile.
    Yoshii M, Une M, Kihira K, Kuramoto T, Hoshita T.
    Chem Pharm Bull (Tokyo); 1989 Jul; 37(7):1852-4. PubMed ID: 2805165
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Determination of the glucurono-conjugated position in bile alcohol glucuronides excreted in urine of a patient with cerebrotendinous xanthomatosis by a nuclear magnetic resonance study.
    Kuramoto T, Fukuda K, Ohshima A, Kihira K, Hoshita T.
    J Biochem; 1994 Apr; 115(4):655-8. PubMed ID: 8089079
    [Abstract] [Full Text] [Related]

  • 20. Increased plasma bile alcohol glucuronides in patients with cerebrotendinous xanthomatosis: effect of chenodeoxycholic acid.
    Batta AK, Salen G, Shefer S, Tint GS, Batta M.
    J Lipid Res; 1987 Aug; 28(8):1006-12. PubMed ID: 3668385
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.